Biotechnology Stocks II Performance Guide: Tango Therapeutics, Inc. (TNGX)
TNGX has no dividends.
Table and Chart of TNGX Performance
See what a $1,000 investment in TNGX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| TNGX Returns | |
|---|---|
| Start Date | Oct-30-2020 |
| Start Price | $9.95 |
| End Date | Jul-26-2024 |
| End Price | $9.75 |
| # Prices | 46 |
| Min Date | May-31-2023 |
| Min Price | $2.70 |
| Max Date | Sep-30-2021 |
| Max Price | $12.93 |
| Total Return | -2.01% |
| Annualized Return | -0.53% |
| Current Value of $1,000 Purchase | $980 |
| Number Returns | 1,035 |
| Average Return | -1.64% |
| Number Profitable Returns | 351 |
| Percent Profitable Returns | 33.91% |
| Number Unprofitable Returns | 684 |
| Percent Unprofitable Returns | 66.09% |
| Profitable to Unprofitable Returns Ratio | 0.51 |
| TNGX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,052,433,000 |
| Beta | 0.832 | Price to Sales | 21.50 |
| Earnings per Share | $-1.1100 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 3.103 |
| PRICE DATA | |
| 52 Week High | $13.03 |
| 52 Week Low | $3.05 |
| Analyst Target Price | $15.38 |
| 50-Day Moving Average | $8.45 |
| 200-Day Moving Average | $9.01 |
| FINANCIAL DATA | |
| Revenue per Share | $0.374 |
| Revenue | $37,232,000 |
| Profit Margin | -299.9% |
| Return on Equity | -45.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
TNGX Compare Returns with S&P 500
TNGX Trendline Chart
TNGX Moving Average Chart
TNGX Stock Return Map - See Patterns of Gains and Losses
TNGX Stock Returns/Purchase Dates